Gamma glutamyl transferase as a biomarker to predict contrast-induced nephropathy among patients with acute coronary syndrome undergoing coronary interventions: a meta-analysis.

MLA

Javid, Mona, et al. “Gamma Glutamyl Transferase as a Biomarker to Predict Contrast-Induced Nephropathy among Patients with Acute Coronary Syndrome Undergoing Coronary Interventions: A Meta-Analysis.” Annals of Medicine and Surgery (2012), vol. 85, no. 8, June 2023, pp. 4033–40. EBSCOhost, https://doi.org/10.1097/MS9.0000000000000967.

APA

Javid, M., Mirdamadi, A., Javid, M., Amini-Salehi, E., Vakilpour, A., Keivanlou, M.-H., Porteghali, P., & Hassanipour, S. (2023). Gamma glutamyl transferase as a biomarker to predict contrast-induced nephropathy among patients with acute coronary syndrome undergoing coronary interventions: a meta-analysis. Annals of Medicine and Surgery (2012), 85(8), 4033–4040. https://doi.org/10.1097/MS9.0000000000000967

Chicago

Javid, Mona, Arian Mirdamadi, Mohammadreza Javid, Ehsan Amini-Salehi, Azin Vakilpour, Mohammad-Hossein Keivanlou, Parham Porteghali, and Soheil Hassanipour. 2023. “Gamma Glutamyl Transferase as a Biomarker to Predict Contrast-Induced Nephropathy among Patients with Acute Coronary Syndrome Undergoing Coronary Interventions: A Meta-Analysis.” Annals of Medicine and Surgery (2012) 85 (8): 4033–40. doi:10.1097/MS9.0000000000000967.